Literature DB >> 26153261

The case for CMR.

Peter W Shaw1, Christopher M Kramer2,3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26153261      PMCID: PMC4915367          DOI: 10.1007/s12350-015-0147-y

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  20 in total

Review 1.  Quantification in cardiac MRI.

Authors:  R J van der Geest; J H Reiber
Journal:  J Magn Reson Imaging       Date:  1999-11       Impact factor: 4.813

2.  Improved detection of myocardial involvement in acute inflammatory cardiomyopathies using T2 mapping.

Authors:  Paaladinesh Thavendiranathan; Michael Walls; Shivraman Giri; David Verhaert; Sanjay Rajagopalan; Sean Moore; Orlando P Simonetti; Subha V Raman
Journal:  Circ Cardiovasc Imaging       Date:  2011-10-28       Impact factor: 7.792

3.  Normal human right and left ventricular mass, systolic function, and gender differences by cine magnetic resonance imaging.

Authors:  C H Lorenz; E S Walker; V L Morgan; S S Klein; T P Graham
Journal:  J Cardiovasc Magn Reson       Date:  1999       Impact factor: 5.364

4.  Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance.

Authors:  Carlos J Soriano; Francisco Ridocci; Jordi Estornell; Javier Jimenez; Vicente Martinez; José A De Velasco
Journal:  J Am Coll Cardiol       Date:  2005-03-01       Impact factor: 24.094

Review 5.  Role of cardiac magnetic resonance imaging in assessment of nonischemic cardiomyopathies.

Authors:  Monda L Shehata; Evrim B Turkbey; Jens Vogel-Claussen; David A Bluemke
Journal:  Top Magn Reson Imaging       Date:  2008-02

6.  Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance.

Authors:  J A McCrohon; J C C Moon; S K Prasad; W J McKenna; C H Lorenz; A J S Coats; D J Pennell
Journal:  Circulation       Date:  2003-06-23       Impact factor: 29.690

Review 7.  Advances in parametric mapping with CMR imaging.

Authors:  Michael Salerno; Christopher M Kramer
Journal:  JACC Cardiovasc Imaging       Date:  2013-07

8.  Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy.

Authors:  Valentina O Puntmann; Tobias Voigt; Zhong Chen; Manuel Mayr; Rashed Karim; Kawal Rhode; Ana Pastor; Gerald Carr-White; Reza Razavi; Tobias Schaeffter; Eike Nagel
Journal:  JACC Cardiovasc Imaging       Date:  2013-03-14

9.  Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis.

Authors:  Theodoros D Karamitsos; Stefan K Piechnik; Sanjay M Banypersad; Marianna Fontana; Ntobeko B Ntusi; Vanessa M Ferreira; Carol J Whelan; Saul G Myerson; Matthew D Robson; Philip N Hawkins; Stefan Neubauer; James C Moon
Journal:  JACC Cardiovasc Imaging       Date:  2013-03-14

10.  T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging.

Authors:  Vanessa M Ferreira; Stefan K Piechnik; Erica Dall'Armellina; Theodoros D Karamitsos; Jane M Francis; Ntobeko Ntusi; Cameron Holloway; Robin P Choudhury; Attila Kardos; Matthew D Robson; Matthias G Friedrich; Stefan Neubauer
Journal:  JACC Cardiovasc Imaging       Date:  2013-09-04
View more
  3 in total

Review 1.  Cardiac MRI for the evaluation of oncologic cardiotoxicity.

Authors:  Adrián I Löffler; Michael Salerno
Journal:  J Nucl Cardiol       Date:  2018-05-07       Impact factor: 5.952

2.  Imaging the patient with a new diagnosis of heart failure in the contemporary era.

Authors:  James E Udelson
Journal:  J Nucl Cardiol       Date:  2015-07-08       Impact factor: 5.952

Review 3.  Non-invasive assessment of low- and intermediate-risk patients with chest pain.

Authors:  Pelbreton C Balfour; Jorge A Gonzalez; Christopher M Kramer
Journal:  Trends Cardiovasc Med       Date:  2016-09-12       Impact factor: 6.677

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.